A detailed history of New Insight Wealth Advisors transactions in Abb Vie Inc. stock. As of the latest transaction made, New Insight Wealth Advisors holds 4,568 shares of ABBV stock, worth $814,885. This represents 0.47% of its overall portfolio holdings.

Number of Shares
4,568
Previous 4,930 7.34%
Holding current value
$814,885
Previous $846 Million 6.68%
% of portfolio
0.47%
Previous 0.5%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.84 - $199.33 $59,310 - $72,157
-362 Reduced 7.34%
4,568 $902 Million
Q2 2024

Aug 15, 2024

SELL
$154.79 - $180.76 $102,161 - $119,301
-660 Reduced 11.81%
4,930 $846 Million
Q1 2024

May 08, 2024

SELL
$159.82 - $182.1 $9,109 - $10,379
-57 Reduced 1.01%
5,590 $1.02 Billion
Q4 2023

May 08, 2024

BUY
$137.6 - $154.97 $777,027 - $875,115
5,647 New
5,647 $875 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track New Insight Wealth Advisors Portfolio

Follow New Insight Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Insight Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on New Insight Wealth Advisors with notifications on news.